Hypersensitivity to Excipients in Drugs: An EAACI Position Paper
Allergy · 2026-07 · 81 (7) · 2250-2275
DOI: 10.1111/all.70324 ↗At a glance
Übersichtsarbeit in Allergy, published online on 2026-04-08. Written by Lene H Garvey and 10 co-authors. Institution: Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, Hellerup, Denmark. Major MEDLINE topics: Excipients, Drug Hypersensitivity. Cited 5 times so far (Crossref); 122 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Fonds Wetenschappelijk Onderzoek, European Academy of Allergy and Clinical Immunology.
Abstract (original language)
Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved. Excipient‐related DHR are easily overlooked and may lead to repeated anaphylaxis in patients exposed to pharmaceutical formulations containing different active ingredients. We performed an extensive review of the literature to provide practical recommendations on when to suspect and how to diagnose and manage excipient hypersensitivity. Where literature was limited, the collective experience of the authors was taken into consideration. Excipient hypersensitivity should be suspected in patients with a history of anaphylaxis to multiple drugs with chemically unrelated active ingredients and specific drug classes such as oral laxatives and injectable depot steroids or progestogens. Polyethylene glycol, methylcelluloses, gelatine, povidone and mannitol were identified as the most common culprits of DHR. DHR evaluation should include review of the product monograph to ascertain the presence of possible culprit excipients. Specific diagnostic tests for excipients should be performed when appropriate, including skin, in vitro and provocation testing with pure excipients and drugs with and without the excipient as controls. We provide consensus‐based excipient‐specific recommendations on diagnostic testing based on best available evidence.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte University Hospital, Hellerup, Denmark.
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Dermatology and Allergy Biederstein, Faculty of Medicine and Health, Technical University Munich, Munich, Germany.
- Service de Dermatologie et Allergologie, Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Hôpital Tenon AP-HP, Sorbonne Université, Paris, France.
- Department of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.
- Research Unit Dermatology and Allergology, University of Southern Denmark, Odense, Denmark.
ORCID profiles: Lene H Garvey, Knut Brockow, Annick Barbaud, Charlotte G Mortz, Gianfranco Calogiuri, Asli Gelincik, Osman O Yeğit, Alla Nakonechna, Rik Schrijvers, Toon Ieven
Funding
- Fonds Wetenschappelijk Onderzoek
- European Academy of Allergy and Clinical Immunology
Cite
APA
Garvey, L. H., Brockow, K., Barbaud, A., Mortz, C. G., Calogiuri, G., Gelincik, A., Yeğit, O. O., Nakonechna, A., Wagner, A., Schrijvers, R., & Ieven, T. (2026). Hypersensitivity to Excipients in Drugs: An EAACI Position Paper. Allergy, 81(7), 2250-2275. https://doi.org/10.1111/all.70324
Vancouver
Garvey LH, Brockow K, Barbaud A, Mortz CG, Calogiuri G, Gelincik A, et al. Hypersensitivity to Excipients in Drugs: An EAACI Position Paper. Allergy. 2026;81(7):2250-2275. doi:10.1111/all.70324
BibTeX
@article{Garvey2026,
author = {Garvey, Lene H and Brockow, Knut and Barbaud, Annick and Mortz, Charlotte G and Calogiuri, Gianfranco and Gelincik, Asli and Yeğit, Osman O and Nakonechna, Alla and Wagner, Annette and Schrijvers, Rik and Ieven, Toon},
title = {Hypersensitivity to Excipients in Drugs: An EAACI Position Paper},
journal = {Allergy},
year = {2026},
volume = {81},
number = {7},
pages = {2250--2275},
doi = {10.1111/all.70324}
}
EUVIMED